Literature DB >> 9538207

Biochemical and functional properties of lysine-specific cysteine proteinase (Lys-gingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease.

N Abe1, T Kadowaki, K Okamoto, K Nakayama, M Ohishi, K Yamamoto.   

Abstract

The oral anaerobic bacterium Porphyromonas gingivalis has been implicated as a major etiologic agent of progressive periodontal disease. A novel lysine-specific cysteine proteinase, termed "Lys-gingipain," was purified from the culture supernatant of the Arg-gingipain-deficient mutant of P. gingivalis (KDP112) by a simple method including immunoaffinity chromatography. The purified enzyme was found to be composed of a single polypeptide of Mr=51,000. Analysis of the enzymatic properties revealed several distinctive features of this enzyme. The proteolytic activity was remarkably activated by thiol-reducing agents and inhibited by idoacetamide, idoacetic acid, and leupeptin. The enzyme was also inhibited by the chloromethyl ketones of tosyl-L-lysine and tosyl-L-phenylalanine. However, internal protease inhibitors, such as cystatins and alpha1-antichymotrypsin, had no effect on the activity, suggesting its resistance to normal host defense systems in vivo. Despite its narrow specificity for synthetic substrates containing Lys in the P1 site, the enzyme extensively degraded human type I collagen and immunoglobulins G and A (both serum and secretory types). Most important, the enzyme was able to disrupt the functions of polymorphonuclear leukocytes, as shown by its inhibitory effect on the generation of active oxygen species from the activated cells. These results suggest that Lys-gingipain, like Arg-gingipain, plays a crucial role as a virulence factor from P. gingivalis in the development of periodontal disease via the direct destruction of periodontal tissue components and the disruption of normal host defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538207     DOI: 10.1093/oxfordjournals.jbchem.a021937

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  25 in total

1.  Localization of HArep-containing genes on the chromosome of Porphyromonas gingivalis W83.

Authors:  J P Lewis; F L Macrina
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  A Porphyromonas gingivalis mutant defective in a putative glycosyltransferase exhibits defective biosynthesis of the polysaccharide portions of lipopolysaccharide, decreased gingipain activities, strong autoaggregation, and increased biofilm formation.

Authors:  Mikiyo Yamaguchi; Keiko Sato; Hideharu Yukitake; Yuichiro Noiri; Shigeyuki Ebisu; Koji Nakayama
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

Review 4.  Oxidative stress resistance in Porphyromonas gingivalis.

Authors:  Leroy G Henry; Rachelle M E McKenzie; Antonette Robles; Hansel M Fletcher
Journal:  Future Microbiol       Date:  2012-04       Impact factor: 3.165

5.  Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact.

Authors:  M Oido-Mori; R Rezzonico; P L Wang; Y Kowashi; J M Dayer; P C Baehni; C Chizzolini
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells.

Authors:  Hamdy Nassar; Hsin-Hua Chou; Mary Khlgatian; Frank C Gibson; T E Van Dyke; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.

Authors:  M Kuboniwa; A Amano; S Shizukuishi; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  vimA gene downstream of recA is involved in virulence modulation in Porphyromonas gingivalis W83.

Authors:  H Abaibou; Z Chen; G J Olango; Y Liu; J Edwards; H M Fletcher
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Regulation of protease expression in Porphyromonas gingivalis.

Authors:  M Tokuda; W Chen; T Karunakaran; H K Kuramitsu
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Metabolic network model of a human oral pathogen.

Authors:  Varun Mazumdar; Evan S Snitkin; Salomon Amar; Daniel Segrè
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.